Unlike standard therapeutic doses used for diabetes or weight loss, microdosing involves administering significantly smaller amounts of Semaglutide
STEP-5 is the longest of the STEP trials, which spanned two years at semaglutide 2.4mg and reported gradual weight loss over the initial 60 weeks
Applications in Research As a molecular probe for studying neuropeptide-mediated signalling in central nervous system models Investigation of peptide interactions within neuroendocrine and stress-related pathways In vitro studies examining peptide stability, degradation, and carrier-protein interactions As a reference compound in research involving short endogenous neuropeptides Handling, Reconstitution & Stability Weigh under dry conditions
While this is beneficial for many, it can also increase the risk of hypoglycemia (low blood sugar)
FEMS Microbiol Rev 38(5):9961047 Roth S, Franken P, Sacchetti A, Kremer A, Anderson K, Sansom O, Fodde R (2012) Paneth cells in intestinal homeostasis and tissue injury